Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 11, 1998, Pages 1419-1424

  Bellier, Bruno ^a   Da Nascimento, Sophie ^a   Meudal, Hervé ^a   Gincel, Edith ^a   Roques, Bernard P ^a   Garbay, Christiane ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Antagonists; Cholecystokinin; Peptoids

Indexed keywords

CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR; PIPECOLIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; DRUG SYNTHESIS; MOLECULAR RECOGNITION; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; CEREBRAL CORTEX; CHO CELLS; CHOLECYSTOKININ; CRICETINAE; GUINEA PIGS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PANCREAS; PIPECOLIC ACIDS; PROTEIN CONFORMATION; RATS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032474536     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00231-5     Document Type: Article

References (18)

1. 1. Reviewed in Crawley, J.N. ; Corwin, R.L. Peptides, 1994, 15, 731-55.
2. 2. Reviewed in Shulkes, A. ; Baldwin, G.S. Clin. Exp. Pharm. Pharmacol., 1997, 24, 209-216.
3. 50s are the concentrations inhibiting 50% of inositol phosphate production triggered by CCK-8 (0.5 nM) in the same cells (see ref.8 for details).
4. 4. Durieux, C. ; Coppey, M. ; Zajac, J.M. ; Roques, B.P. Biochem. Biophys. Res. Commun., 1986, 137, 1167-1173.
5. 5. Derrien, M. ; McCort-Tranchepain, I. ; Ducos, B. ; Roques, B.P. ; Durieux, C. Pharmacol. Biochem. Behav., 1994, 49, 133-141.
6. 6. Léna, I. ; Roques, B.P. ; Durieux, C. J. Neurochem., 1997, 68, 162-168.
7. 7. Harper, E.A. ; Roberts, S.P. ; Shankley, N.R. ; Black, J.W. Br. J. Pharmacol., 1996, 118, 1717-1726.
8. 8. Bellier, B. ; McCort, I. ; Ducos, B. ; Da Nascimento, S. ; Meudal, H. ; Noble, F. ; Garbay, C. ; Roques, B.P. J. Med. Chem, 1997, 40, 3947-3956.
9. 9. Blommaert, A.G.S. ; Weng, J.H. ; Dorville, A. ; McCort, I. ; Ducos, B. ; Durieux, C. ; Roques, B.P. J. Med. Chem, 1993, 36, 2868-2877.
10. 10. Gillard, J. ; Abraham, A. ; Anderson, P.C. ; Beaulieu, P.L. ; Bogri, T. ; Bousquet, Y. ; Grenier, L. ; Guse, I. ; Lavallée, P. J. Org. Chem., 1996, 61, 2226-2231.
11. 11. Mitsunobu, O. Synthesis, 1981, 1-28.
12. 12. Guttmann, S. ; Boissonnas, R.A. Helv. Chim. Acta, 1958, 41, 1852-1867.
13. 13. Typical experimental procedure for Mitsunobu reaction using (N-Boc)-4-hydroxypipecolic acid methyl ester : triphenylphosphine (1.5 mmol) and diethylazodicarboxylate (1.5 mmol) were dissolved in 3 mL ice-cooled distilled THF and stirred for 1 hour. Formic acid (or respectively 2,4-dichlorophenol) (1.5 mmol) was added and the solution stirred for an additional half hour. A solution of the hydroxy acid (1 mmol in 2 mL of THF) was then added dropwise for approximately 1 hour, and the mixture was stirred overnight at r.t.. The desired compound was obtained after evaporation and column chromatography.
14. 14. Golubev, A. ; Sewald, N. ; Burger, K. Tetrahedron, 1996, 52, 14757-14776.
15. 15. Holladay, M.W. ; Bennett, M.J. ; Bai, H. ; Ralston, J.W. ; Kerwin, J.F.Jr. ; Stashko, M. ; Miller, T.R. ; O'Neill, A.B. ; Nadzan, A.M. ; Brioni, J. ; Lin, C.W. Bioorg. Med. Chem. Lett., 1995, 5, 3057-3062.
16. 16. Biological experiments were performed following the procedures described in ref.8.
17. 17. González-Muñiz, R. ; Dóminguez, M.J. ; Martín-Martínez, M. ; Herranz, R. ; García-López, M.T. ; Barber, A. ; Ballaz, S. ; Del Río, J. Bioorg. Med. Chem. Lett., 1996, 6, 967-972.
18. 18. Batt, A.R. ; Kendrick, D.A. ; Mathews, E. ; Rooker, D.P. ; Ryder, H. ; Semple, G. ; Szelke, K. Bioorg. Med. Chem. Lett., 1994, 4, 867-872.